Basic information Safety Supplier Related

Ganitumab

Basic information Safety Supplier Related

Ganitumab Basic information

Product Name:
Ganitumab
Synonyms:
  • Ganitumab
  • Research Grade Ganitumab (DHC29902)
  • AMG 479
  • Research Grade Ganitumab
  • Ganitumab (anti-IGF1R)
  • Ganitumab 4.92mg/ml
CAS:
905703-97-1
MW:
0
Mol File:
Mol File
More
Less

Ganitumab Chemical Properties

form 
Liquid
color 
Colorless to light yellow
More
Less

Ganitumab Usage And Synthesis

Uses

Ganitumab (AMG 479) is a recombinant human monoclonal antibody to the human type 1 insulin-like growth factor receptor (IGF1R). Ganitumab recognizes murine IGF1R with sub-nanomolar affinity (KD=0.22 nM) and inhibits the interaction of murine IGF1R with IGF1 and IGF2. Ganitumab can be used in research of cancer[1].

in vivo

Ganitumab (AMG 479; 1 mg/dose; i.p; Na?ve and tumor-bearing mice) inhibits IGF1-induced activation of mIGF1R in murine lungs[1].
Ganitumab (300 μg/dose; i.p.; female athymic nude mice) reduces peripheral blood neutrophils[1].
Ganitumab (300 μg/dose; i.p.; male athymic nude mice) causes impaired glucose tolerance in male mice and increases serum levels of mGH, mIGF1 and mIGFBP3[1].

Animal Model:Na?ve and tumor-bearing mice[1]
Dosage:1 mg/dose
Administration:Intraperitoneal injection
Result:Inhibited the IGF1-induced activation of mIGF1R and inhibited 80% tumor growth.
Animal Model:Male athymic nude mice[1]
Dosage:300 μg/dose
Administration:Intraperitoneal injection, twice per week for a total of five doses
Result:Had significantly higher serum glucose levels than hIgG1-pretreated mice.
Increased serum levels of mIGF1, mIGFPB3 and mGH.
Animal Model:Female athymic nude mice[1]
Dosage:300 μg/dose
Administration:Intraperitoneal injection, twice per week for a total of five doses
Result:Reduced the number of peripheral neutrophils up to 50% compared with hIgG1 controls.

References

[1] Moody G, et, al. IGF1R blockade with ganitumab results in systemic effects on the GH-IGF axis in mice. J Endocrinol. 2014 Mar 17;221(1):145-55. DOI:10.1530/JOE-13-0306

GanitumabSupplier

Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Email
3008007409@qq.com
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Email
2853530910@QQ.com
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
DC Chemicals
Tel
021-58447131 13564518121
Email
doncunbiosci@gmail.com
Guangzhou Hongyuan Chemical Co.,Ltd
Tel
15817493340
Email
981810490@qq.com